止血和組織密封劑市場規模、佔有率和成長分析（按產品、材料、應用、最終用途和地區）- 產業預測 2025-2032

2023 年全球止血和組織密封劑市場規模價值 74.1 億美元，預計將從 2024 年的 80.1 億美元成長到 2032 年的 149.4 億美元，預測期內（2025-2032 年）的複合年成長率為 8.1%。

由於慢性病發病率上升和人口老化導致外科手術需求不斷增加，全球止血和組織密封劑市場正在經歷強勁成長。外科手術的激增需要有效的止血和密封產品來提高病人的安全。微創手術和先進手術技術的創新進一步增加了這種需求。製造商在研發上的持續投入，帶來了功效更高、副作用更少的創新產品，贏得了醫療專業人士的信任。然而，市場面臨嚴格的監管核准、高昂的醫療成本和報銷問題等挑戰，這些可能會阻礙新技術的採用。此外，競爭對手之間的激烈競爭導致價格壓力，需要不斷投資於研究和行銷策略以維持市場地位。

目錄

介紹

• 調查目的
• 研究範圍
• 定義

調查方法

• 資訊採購
• 資料和主要資料方法
• 市場規模預測
• 市場假設與限制

執行摘要

• 全球市場展望
• 供需趨勢分析
• 細分機會分析

市場動態及展望

• 市場概況
• 市場規模
• 市場動態
  • 促進因素和機會
  • 限制與挑戰
• 波特的分析

主要市場考察

• 關鍵成功因素
• 競爭程度
• 主要投資機會
• 市場生態系統
• 市場吸引力指數（2024 年）
• PESTEL 分析
• 總體經濟指標
• 價值鏈分析
• 定價分析
• 原料分析

止血和組織密封劑市場規模（按產品和複合年成長率） (2025-2032)

• 市場概況
• 局部止血劑
  • 動態的
  • 機械的
  • 流動性
• 黏合劑和組織密封膠
  • 合成組織組織密封膠
  • 天然組織密封膠
  • 防沾黏劑

止血和組織密封劑市場規模（按材料和複合年成長率） (2025-2032)

• 市場概況
• 明膠基局部止血劑
• 膠原蛋白局部外用止血劑
• 基於ORC的局部止血劑
• 多醣類局部止血劑

止血和組織密封劑市場規模（按應用和複合年成長率）（2025-2032）

• 市場概況
• 一般外科
• 神經外科
• 血管外科
• 心血管外科
• 其他

止血和組織密封劑市場規模（按最終用途和複合年成長率分類）（2025-2032 年）

• 市場概況
• 醫院
• 門診手術中心
• 家庭護理設置
• 其他

止血及組織密封劑市場規模（按地區分類）及複合年成長率（2025-2032）

• 北美洲
  • 美國
  • 加拿大
• 歐洲
  • 德國
  • 西班牙
  • 法國
  • 英國
  • 義大利
  • 其他歐洲國家地區
• 亞太地區
  • 中國
  • 印度
  • 日本
  • 韓國
  • 其他亞太地區
• 拉丁美洲
  • 巴西
  • 其他拉丁美洲國家
• 中東和非洲
  • 海灣合作理事會國家
  • 南非
  • 其他中東和非洲地區

競爭資訊

• 前 5 家公司對比
• 主要企業市場定位（2024年）
• 主要市場參與者所採用的策略
• 近期市場趨勢
• 公司市場佔有率分析（2024 年）
• 主要企業簡介
  • 公司簡介
  • 產品系列分析
  • 按細分市場分析市場佔有率
  • 收益與前一年同期比較對比（2022-2024 年）

主要企業簡介

• Johnson & Johnson（United States）
• Baxter International Inc.（United States）
• Pfizer Inc.（United States）
• Integra LifeSciences Corporation（United States）
• Smith & Nephew plc（United Kingdom）
• B. Braun Melsungen AG（Germany）
• CryoLife, Inc.（United States）
• CSL Behring（Australia）
• Medtronic plc（Ireland）
• Zimmer Biomet Holdings, Inc.（United States）
• Ferrosan Medical Devices A/S（Denmark）
• Cohera Medical, Inc.（United States）
• Marine Polymer Technologies, Inc.（United States）
• Equimedical BV（Netherlands）
• Advanced Medical Solutions Group plc（United Kingdom）
• Cohesion Technologies, Inc.（United States）
• HyperBranch Medical Technology, Inc.（United States）
• Terumo Corporation（Japan）
• Mil Laboratories Pvt. Ltd.（India）

結論和建議

Global Hemostasis and Tissue Sealing Agents Market size was valued at USD 7.41 billion in 2023 and is poised to grow from USD 8.01 billion in 2024 to USD 14.94 billion by 2032, growing at a CAGR of 8.1% during the forecast period (2025-2032).

The global hemostasis and tissue sealing agents market is witnessing robust growth, fueled by rising chronic disease incidences and an aging demographic, which increases the demand for surgical procedures. This surge in surgeries necessitates effective hemostatic and sealing products to enhance patient safety. Innovations in minimally invasive surgery and advanced surgical techniques further amplify this demand. Continuous R&D investments by manufacturers are resulting in innovative products with enhanced efficacy and minimal side effects, earning the trust of healthcare professionals. However, the market faces challenges, including stringent regulatory approvals, high healthcare costs, and reimbursement issues, which could hinder the adoption of new technologies. Additionally, intense competition among players leads to pricing pressures, requiring ongoing investments in research and marketing strategies to sustain market presence.

Top-down and bottom-up approaches were used to estimate and validate the size of the Global Hemostasis And Tissue Sealing Agents market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Global Hemostasis And Tissue Sealing Agents Market Segments Analysis

Global Hemostasis and Tissue Sealing Agents Market is segmented by Product, Material, Application, End-use and region. Based on Product, the market is segmented into Topical Hemostats and Adhesive & Tissue Sealant. Based on Material, the market is segmented into Gelatin-based Topical Hemostats, Collagen-based Topical Hemostats, ORC-based Topical Hemostats and Polysaccharide-based Topical Hemostats. Based on Application, the market is segmented into General Surgery, Neurosurgery, Vascular Surgery, Cardiovascular Surgery and Others. Based on End-use, the market is segmented into Hospitals, Ambulatory Surgical Centers, Home Care Settings and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Global Hemostasis And Tissue Sealing Agents Market

The increasing inclination towards minimally invasive surgical methods has significantly heightened the demand for specialized hemostasis and tissue sealing agents utilized in laparoscopic, endoscopic, and robotic-assisted procedures. These agents are crucial in achieving effective hemostasis and securing tissue closure during surgeries that prioritize reduced invasiveness. Their ability to enhance surgical outcomes and minimize complications has made them essential in contemporary surgical practices. As the medical field continues to emphasize patient comfort and faster recovery times, the global market for these innovative hemostatic and sealing agents is expected to grow, reflecting the evolving landscape of surgical techniques and patient care.

Restraints in the Global Hemostasis And Tissue Sealing Agents Market

The Global Hemostasis and Tissue Sealing Agents market faces notable constraints stemming from the lengthy and expensive approval process associated with new products. Stringent regulatory standards necessitate extensive testing and documentation, which can significantly impede the introduction of innovative agents. As a result, the development cycle is prolonged, leading to delays in the commercialization of new offerings. This not only restricts market growth but also limits the availability of advanced treatments for patients, ultimately affecting the competitive landscape in this vital industry. Consequently, manufacturers may encounter challenges in bringing their products to market efficiently.

Market Trends of the Global Hemostasis And Tissue Sealing Agents Market

The Global Hemostasis and Tissue Sealing Agents market is experiencing a robust trend fueled by the rising preference for minimally invasive surgical procedures. This shift is largely driven by the benefits these techniques offer, including reduced incision sizes, minimized scarring, and expedited recovery times for patients. Consequently, there is an increasing demand for specialized hemostasis and tissue sealing agents that ensure optimal wound closure and effective tissue adhesion during these surgeries. As healthcare providers continue to adopt advanced surgical methodologies, the market for these agents is expected to expand significantly, presenting lucrative opportunities for manufacturers and suppliers in the region.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Raw Material Analysis

Global Hemostasis and Tissue Sealing Agents Market Size by Product & CAGR (2025-2032)

• Market Overview
• Topical Hemostats
  • Active
  • Mechanical
  • Flowable
• Adhesive & Tissue Sealant
  • Synthetic Tissue Sealant
  • Natural Tissue Sealant
  • Adhesion Barrier Products

Global Hemostasis and Tissue Sealing Agents Market Size by Material & CAGR (2025-2032)

• Market Overview
• Gelatin-based Topical Hemostats
• Collagen-based Topical Hemostats
• ORC-based Topical Hemostats
• Polysaccharide-based Topical Hemostats

Global Hemostasis and Tissue Sealing Agents Market Size by Application & CAGR (2025-2032)

• Market Overview
• General Surgery
• Neurosurgery
• Vascular Surgery
• Cardiovascular Surgery
• Others

Global Hemostasis and Tissue Sealing Agents Market Size by End-use & CAGR (2025-2032)

• Market Overview
• Hospitals
• Ambulatory Surgical Centers
• Home Care Settings
• Others

Global Hemostasis and Tissue Sealing Agents Market Size & CAGR (2025-2032)

• North America (Product, Material, Application, End-use)
  • US
  • Canada
• Europe (Product, Material, Application, End-use)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product, Material, Application, End-use)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product, Material, Application, End-use)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product, Material, Application, End-use)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• Johnson & Johnson (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Baxter International Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Pfizer Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Integra LifeSciences Corporation (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Smith & Nephew plc (United Kingdom)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• B. Braun Melsungen AG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• CryoLife, Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• CSL Behring (Australia)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Medtronic plc (Ireland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Zimmer Biomet Holdings, Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Ferrosan Medical Devices A/S (Denmark)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cohera Medical, Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Marine Polymer Technologies, Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Equimedical B.V. (Netherlands)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Advanced Medical Solutions Group plc (United Kingdom)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Cohesion Technologies, Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• HyperBranch Medical Technology, Inc. (United States)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Terumo Corporation (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Mil Laboratories Pvt. Ltd. (India)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations